The $296 Billion Tumour
There is a $296 billion tumour growing between marketing departments and the agencies they hire.
It is fed by a $140 billion research industry that cannot see it, validated by a $35 billion consulting industry that will not name it, and sustained by a structural incentive on both sides of the table to pretend it does not exist.
It is the gap between what companies believe they sell and what customers actually buy. And it is metastasizing through every campaign, every brief, every pitch, and every board presentation built on assumptions that nobody has validated against external reality.
That $296 billion is not a guess. Marketers themselves report wasting 26% of their budgets on ineffective strategies and misaligned audiences. Apply that to $1.14 trillion in global ad spend, and the number writes itself. Meanwhile, the market research industry, which exists to prevent this waste, relies on methodologies that predict only 34% of what respondents say. The consultants hired to diagnose the problem charge $250,000 per engagement to tell clients what they want to hear. And the agencies paid to execute against the strategy built on briefs they privately know are wrong.
Two industries. One shared delusion. And neither side can break the cycle alone — because the system itself is engineered to prevent it.
Subscribe to continue reading
Become a paid subscriber to get access to the rest of this post and other exclusive content.
